What stocks does quant Healthcare Fund hold?

quant Healthcare Fund holds a portfolio of Indian equity stocks disclosed monthly by Quant Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages quant Healthcare Fund?

quant Healthcare Fund is managed by Quant Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is quant Healthcare Fund?

quant Healthcare Fund is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is quant Healthcare Fund portfolio data updated?

Portfolio holdings for quant Healthcare Fund are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Quant Mutual Fund

quant Healthcare Fund - Growth Option - Direct Plan

Equity Data as of Aug 2026 Comparing Jul 2026 → Aug 2026

Share: WhatsApp X

⌕

Stocks Held

Aug 2026

Equity Holdings

₹301.21 Cr

Equity only, excl. debt & cash

AAUM

₹361.15 Cr

Apr-Jun 2026 · Direct + Regular

Top 5 Weight

43.8%

High concentration

Top 10 Weight

70.0%

High concentration

Changes

1 new · 2 exits

Top Sector

Pharmaceuticals & Biotechnology

64.4% of portfolio

Launch Date

27 Jun 2023

3 years old

AAUM (Average Assets Under Management) of ₹361.15 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month quant Healthcare Fund made 1 new addition and exited 2 stocks this month. The biggest new buy was Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology) at 9.30% weight. Aster DM Healthcare Limited was the biggest exit (Healthcare Services), which was held at 9.25%. Among existing holdings, Pfizer Limited saw the biggest increase — now at 8.83% of the portfolio. Zydus Wellness Limited was trimmed the most, now at 5.64%. GlaxoSmithKline Pharmaceuticals Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.4%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · quant Healthcare Fund - Growth Option - Direct Plan

+2.81%

+12.05%

+26.14%

+18.66%

Latest NAV

₹19.22

11 Sep 2026

52W High

₹19.46

-1% from High

52W Low

₹13.73

+40% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-3.6%

2024

+31.9%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

15.9%

+ve in 74% windows

70.1% / -12.4%

3Y Rolling Avg

23.4% p.a.

+ve in 100% windows

24.0% / 22.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-24.5%

Rec: Jun 2026 (1yr 11mo)

COVID-19 Crash

Pre-inception

Rec: N/A

2022 Rate Hike

Pre-inception

Rec: N/A

2018 IL&FS

Pre-inception

Rec: N/A

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

0.94

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

1.33

Penalises downside volatility only.

Std Deviation (3Y)

17.2%

Lower = more consistent returns.

NAV Chart ₹19.22 11 Sep 2026

Simple Moving Avg: Click to draw · click again to remove

quant Healthcare Fund - Growth Option - Direct Plan

Chart shows indexed performance (base = 100). Actual NAV: ₹19.22

Sector Shift Industry allocation month-over-month

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	39.8%	53.6%	▲ +13.8%
Food Products	9.4%	9.3%	▼ -0.1%
Healthcare Services	11.0%	9.3%	▼ -1.7%
Telecom - Services	10.8%	7.9%	▼ -2.9%
Fertilizers & Agrochemicals	0.0%	0.3%	▲ +0.3%

Jul 2026 → Aug 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	53.6%	64.4%	▲ +10.8%
Food Products	9.3%	5.6%	▼ -3.7%
Fertilizers & Agrochemicals	0.3%	0.3%	● 0.0%
Healthcare Services	9.3%	0.0%	▼ -9.3%
Telecom - Services	7.9%	0.0%	▼ -7.9%

🟢

Biggest New Buy

Zydus Lifesciences Limited

9.30% weight · Pharmaceuticals & Biotechnology

🔴

Biggest Exit

Aster DM Healthcare Limited

9.25% was held · Healthcare Services

↑

Biggest Add

Pfizer Limited

+3.01% · now 8.83%

↓

Biggest Trim

Zydus Wellness Limited

-3.69% · now 5.64%

🤝 Other funds also bought this month

Zydus Lifesciences Limited 27 funds

👋 Other funds also exited

Aster DM Healthcare Limited 25 funds

HFCL Limited 8 funds

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Aug 2026

Jul 2026 → Aug 2026

🟢 1 New Entry 🔴 2 Exits ↑ 5 Increased ↓ 5 Decreased

#	Stock	Sector	Weight (Aug 2026)
1	Zydus Lifesciences Limited ₹39.82 Cr	Pharmaceuticals & Biotechnology	9.30%

#	Stock	Sector	Last Weight (Jul 2026)
1	Aster DM Healthcare Limited ₹36.72 Cr	Healthcare Services	9.25%
2	HFCL Limited ₹31.35 Cr	Telecom - Services	7.89%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Pfizer Limited ₹37.81 Cr	Pharmaceuticals & Biotechnology	5.82%	8.83%	+3.01%
2	Alivus Life Sciences ₹34.62 Cr	Pharmaceuticals & Biotechnology	7.19%	8.08%	+0.89%
3	GlaxoSmithKline Pharmaceuticals Limited ₹45.31 Cr	Pharmaceuticals & Biotechnology	9.93%	10.58%	+0.65%
4	IPCA Laboratories Limited ₹26.63 Cr	Pharmaceuticals & Biotechnology	5.93%	6.22%	+0.29%
5	Aurobindo Pharma Limited ₹22.18 Cr	Pharmaceuticals & Biotechnology	5.14%	5.18%	+0.04%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Zydus Wellness Limited ₹24.18 Cr	Food Products	9.33%	5.64%	-3.69%
2	Concord Biotech Limited ₹30.13 Cr	Pharmaceuticals & Biotechnology	9.66%	7.03%	-2.63%
3	SMS Pharmaceuticals Limited ₹28.73 Cr	Pharmaceuticals & Biotechnology	7.27%	6.71%	-0.56%
4	Strides Pharma Science Limited ₹10.48 Cr	Pharmaceuticals & Biotechnology	2.64%	2.45%	-0.19%
5	Sumitomo Chemical India Limited ₹1.32 Cr	Fertilizers & Agrochemicals	0.33%	0.31%	-0.02%

What Stocks Does This Fund Hold?

11 stocks — Aug 2026

#	Stock	Sector	Weight & Value
1	GlaxoSmithKline Pharmaceuticals Limited ₹45.31 Cr	Pharmaceuticals & Biotechnology	10.58%
2	Zydus Lifesciences Limited ₹39.82 Cr	Pharmaceuticals & Biotechnology	9.30%
3	Pfizer Limited ₹37.81 Cr	Pharmaceuticals & Biotechnology	8.83%
4	Alivus Life Sciences ₹34.62 Cr	Pharmaceuticals & Biotechnology	8.08%
5	Concord Biotech Limited ₹30.13 Cr	Pharmaceuticals & Biotechnology	7.03%
6	SMS Pharmaceuticals Limited ₹28.73 Cr	Pharmaceuticals & Biotechnology	6.71%
7	IPCA Laboratories Limited ₹26.63 Cr	Pharmaceuticals & Biotechnology	6.22%
8	Zydus Wellness Limited ₹24.18 Cr	Food Products	5.64%
9	Aurobindo Pharma Limited ₹22.18 Cr	Pharmaceuticals & Biotechnology	5.18%
10	Strides Pharma Science Limited ₹10.48 Cr	Pharmaceuticals & Biotechnology	2.45%
11	Sumitomo Chemical India Limited ₹1.32 Cr	Fertilizers & Agrochemicals	0.31%